Market Cap 52.42M
Revenue (ttm) 0.00
Net Income (ttm) -13.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 96,800
Avg Vol 3,149,424
Day's Range N/A - N/A
Shares Out 45.59M
Stochastic %K 55%
Beta 0.03
Analysts Strong Sell
Price Target $3.25

Company Profile

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral,...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 650 216 3500
Address:
1850 Gateway Drive, Suite 175, San Mateo, United States
RyGuy_79
RyGuy_79 Oct. 24 at 3:04 PM
0 · Reply
bobmoney
bobmoney Oct. 24 at 2:46 PM
$TLPH $CRMD CRMD's recent -- strategic investment -- in TLPH up over 100%... CRMD CEO NOW on the Board of TLPH... w/ CEO Joe issued about 40,000 shares of TLPH... TLPH's Phase 3 trials at the Best of the Best of USA medical sites... lead by Primary Investigators that are Nephrologists... !
0 · Reply
bobmoney
bobmoney Oct. 24 at 2:25 PM
$CRMD $TLPH TLPH's top line Phase 3 data on or before December 31, 2025... If TLPH's Niyad is FDA approved... Niyad would be the -- 1st FDA approved anticoagulant for Kidney dialysis in the Extracorporeal Circuit... also likely -- Lungs & Heart... -- HUGE folks & -- count down -- !!
0 · Reply
stevenryl86
stevenryl86 Oct. 24 at 7:44 AM
$TLPH are we in quiet mode? Not much of attention on this
0 · Reply
bobmoney
bobmoney Oct. 23 at 3:35 PM
$CRMD $TLPH Why it matters... TLPH's Niyad Phase 3 data on or before -- December 31, 2025 -- --- Niyad would be the 1st FDA approved... --- !
0 · Reply
RyGuy_79
RyGuy_79 Oct. 23 at 1:52 PM
$TLPH Looks good for liftoff.
0 · Reply
nazzangr
nazzangr Oct. 23 at 2:17 AM
$TLPH i agree! one thing i can say with 100% confidence is that there will be no other drugs like this that has as low risk as nafamostat has when it comes to fda approval. if you are investing in some gene therapy and chemotherapy pharmaceutical and call this a high risk, we got nothing to discuss.
0 · Reply
stevenryl86
stevenryl86 Oct. 22 at 8:25 PM
$TLPH I did My own DD earlier, it will not fail or I can at least failure very low %. https://www.reddit.com/r/pennystocks/s/lSwe6f0736
0 · Reply
CaliEmpress
CaliEmpress Oct. 22 at 8:17 PM
$TLPH Someone somewhere knows something. The rest of us will know about it later this week or next week. I would bet money on it.
1 · Reply
VictoryFormation
VictoryFormation Oct. 22 at 8:06 PM
$TLPH Why is TLPH showing at $0.0 on StockTwits right now?
1 · Reply
Latest News on TLPH
Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:10 PM EDT - 2 months ago

Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript


Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript

May 14, 2025, 9:01 PM EDT - 5 months ago

Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript


Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 6:33 PM EDT - 7 months ago

Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript


Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:43 PM EST - 1 year ago

Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript


Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 6:39 PM EDT - 1 year ago

Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript


Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript

May 14, 2024, 6:21 PM EDT - 1 year ago

Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript


Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 9:48 PM EST - 1 year ago

Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript


RyGuy_79
RyGuy_79 Oct. 24 at 3:04 PM
0 · Reply
bobmoney
bobmoney Oct. 24 at 2:46 PM
$TLPH $CRMD CRMD's recent -- strategic investment -- in TLPH up over 100%... CRMD CEO NOW on the Board of TLPH... w/ CEO Joe issued about 40,000 shares of TLPH... TLPH's Phase 3 trials at the Best of the Best of USA medical sites... lead by Primary Investigators that are Nephrologists... !
0 · Reply
bobmoney
bobmoney Oct. 24 at 2:25 PM
$CRMD $TLPH TLPH's top line Phase 3 data on or before December 31, 2025... If TLPH's Niyad is FDA approved... Niyad would be the -- 1st FDA approved anticoagulant for Kidney dialysis in the Extracorporeal Circuit... also likely -- Lungs & Heart... -- HUGE folks & -- count down -- !!
0 · Reply
stevenryl86
stevenryl86 Oct. 24 at 7:44 AM
$TLPH are we in quiet mode? Not much of attention on this
0 · Reply
bobmoney
bobmoney Oct. 23 at 3:35 PM
$CRMD $TLPH Why it matters... TLPH's Niyad Phase 3 data on or before -- December 31, 2025 -- --- Niyad would be the 1st FDA approved... --- !
0 · Reply
RyGuy_79
RyGuy_79 Oct. 23 at 1:52 PM
$TLPH Looks good for liftoff.
0 · Reply
nazzangr
nazzangr Oct. 23 at 2:17 AM
$TLPH i agree! one thing i can say with 100% confidence is that there will be no other drugs like this that has as low risk as nafamostat has when it comes to fda approval. if you are investing in some gene therapy and chemotherapy pharmaceutical and call this a high risk, we got nothing to discuss.
0 · Reply
stevenryl86
stevenryl86 Oct. 22 at 8:25 PM
$TLPH I did My own DD earlier, it will not fail or I can at least failure very low %. https://www.reddit.com/r/pennystocks/s/lSwe6f0736
0 · Reply
CaliEmpress
CaliEmpress Oct. 22 at 8:17 PM
$TLPH Someone somewhere knows something. The rest of us will know about it later this week or next week. I would bet money on it.
1 · Reply
VictoryFormation
VictoryFormation Oct. 22 at 8:06 PM
$TLPH Why is TLPH showing at $0.0 on StockTwits right now?
1 · Reply
barlaw
barlaw Oct. 22 at 7:49 PM
$TLPH Kind of a stealth ticker it seems, for some odd reason. Continued low volume days with bullish price action after securing compliance. Could she be fixin’ to run away? Or do we revisit the $1.05 area? Bit of an inverse H&S here, but could be a short term, low volume random thing.
0 · Reply
SGP
SGP Oct. 22 at 6:25 PM
$CRMD if we buy $TLPH shares in the open mkt will crmd have to report that? That would be a good plan to afford the buy out. NO!
2 · Reply
bobmoney
bobmoney Oct. 22 at 5:40 PM
$CRMD $TLPH -- TLPH under accumulation... -- Buying kicked in... CRMD ? !
0 · Reply
barlaw
barlaw Oct. 22 at 5:22 PM
$TLPH Touched $1.08 but with barely 1,000 shares traded. The algos gave them to someone else; skipped my limit order. Ah well. It’s GTC.
0 · Reply
bobmoney
bobmoney Oct. 22 at 5:01 PM
$TLPH always a Buyer too...
0 · Reply
nazzangr
nazzangr Oct. 22 at 4:47 PM
$TLPH sellers market today
0 · Reply
bobmoney
bobmoney Oct. 22 at 3:34 PM
$CRMD $TLPH CRMD CEO brilliant pharma background... CRMD -- brilliant -- strategic investment in TLPH...well explained in video... !
0 · Reply
bobmoney
bobmoney Oct. 22 at 2:10 PM
$CRMD $TLPH TLPH 8K this morning, TLPH -- regained NASDAQ compliance -- TLPH's Niyad pivotal Phase 3 clinical data on or around December 31, 2025... If Niyad FDA approved, -- the 1st FDA approved for indication... -- TLPH's Niyad potential medical treatment Game changer! !
0 · Reply
nazzangr
nazzangr Oct. 22 at 2:07 PM
$TLPH if tlph gets absorbed by crmd. I might keep those shares for the longhaul. So far crmd looks very promising on my dd. I need to do more research though
0 · Reply
bobmoney
bobmoney Oct. 22 at 1:29 PM
$TLPH yep, 8K out this morning... Talphera has regained NASDAQ compliance; congrats
0 · Reply
BioAmerica
BioAmerica Oct. 22 at 12:53 PM
$TLPH Here is the important part of the 8K: "On October 20, 2025, we were notified that we had regained compliance with such minimum price requirement, as the closing bid price of our common stock had been at least $1.00 per share for a minimum of 10 consecutive business days ending October 17, 2025."
0 · Reply
stevenryl86
stevenryl86 Oct. 22 at 12:45 PM
$TLPH compliance done, they released in latest 8K
0 · Reply